Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging
Article in Frontiers in Medicine (January 2024)
The most recent citing publications are shown below. View all 73 publications that cite this research output on Dimensions.
Article in Frontiers in Medicine (January 2024)
Article in Rheumatology (January 2024)
Article in Revista Paulista de Pediatria (January 2024)